男性不妊症の世界市場2020-2026:治療別(生殖補助医療・精索静脈瘤手術、投薬)、検査別、地域別

◆英語タイトル:Global Male Infertility Market By Treatment (Assisted Reproductive Technology & Varicocele Surgery and Medication), By Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests), By Region, Industry Analysis and Forecast, 2020 - 2026
◆商品コード:KBV20OCT059
◆発行会社(リサーチ会社):KBV Research
◆発行日:2020年6月30日
◆ページ数:173
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ、カナダ、メキシコ、ロシア、ドイツ、イギリス、フランス、スペイン、イタリア、中国、日本、インド、韓国、シンガポール、マレーシア、ブラジル、アルゼンチン、アラブ首長国連邦、サウジアラビア、南アフリカ、ナイジェリア
◆販売価格オプション(消費税別)
Single User(1名様利用)USD3,600 ⇒換算¥388,800見積依頼/購入/質問フォーム
Global License(法人利用)USD6,048 ⇒換算¥653,184見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKBV Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
KBV Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、男性不妊症の世界市場について、市場範囲・調査手法、市場概要、治療別(生殖補助医療・精索静脈瘤手術、投薬)分析、検査別分析、地域別分析、企業概要などを総合的、多面的に調査・分析しました。
・市場範囲・調査手法
・市場概要
・男性不妊症の世界市場規模:治療別(生殖補助医療・精索静脈瘤手術、投薬)
・男性不妊症の世界市場規模:検査別
・男性不妊症の世界市場規模:地域別
・企業概要
【レポートの概要】

The Global Male Infertility Market size is expected to reach $3.2 billion by 2026, rising at a market growth of 7.6% CAGR during the forecast period. Male infertility is the inability of a male to cause pregnancy in a fertile female. A male’s fertility relies mainly on the quantity and quality of their sperms. If a man’s sperm count is small or if the sperm is of poor quality, it would be difficult, and even impossible, for him to cause pregnancy. The problem of infertility is widespread. Male fertility includes the normal functioning of the hypothalamus, pituitary gland, and testes. Nonetheless, 40 percent-50 percent of cases have no identifiable cause and 30 percent-40 percent of cases are due to problems in the testes.

Continuous R&D efforts are being made to better understand the idiopathic world of infertility. As a result, companies are investing in the development of root cause identification and targeted treatment devices. In addition, the production and commercialization of hormonal therapy are expected to fuel the demand for male infertility during the forecast period. Governments in different countries have taken steps to boost the recovery scenario for infertility-related therapies. In addition, improved safety of patient data due to standardization of legislation is expected to increase consumer demand for infertility treatment.

Advancements in medical testing and rising infertility in males are two of the main factors driving the demand for male infertility. In addition, lifestyle-associated disorders causing infertility, rising obesity, and the expanding aging population are likely to boost the market growth over the forecast period. In the U.S., one-third of cases of infertility are attributed to female factors, one third to male causes, and the other one third is uncertain.

ARTs are used to cure major factors responsible for male infertility. These factors range from sperm autoantibodies, viral orchitis, epididymal dysfunction, accessory gland infections, chemotherapy, to heat, trauma, and other idiopathic factors. High treatment costs and the requirement for several other treatment cycles are some of the key factors contributing to the growth of the segment. Growing spending on health care in developed countries, raising awareness of male infertility, and growing acceptance in middle and low-income countries are the main factors projected to drive the ART segment over the forecast period.

Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.

Scope of the Study
Market Segmentation:

By Treatment
• Assisted Reproductive Technology & Varicocele Surgery and
• Medication

By Tests
• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Computer Assisted Semen Analysis
• Microscopic Examination
• Sperm Agglutination
• Sperm Penetration Assay and
• Other Tests

By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA

Companies Profiled
• Sanofi S.A.
• Bayer AG
• Cadila Healthcare Ltd. (Zydus Cadila)
• Endo International PLC
• Aytu BioScience, Inc.
• Vitrolife AB
• SCSA Diagnostics, Inc.
• Andrology Solutions Limited
• Halotech DNA SL
• Intas Pharmaceutical Ltd.

Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

【レポートの目次】

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Male Infertility Market, by Treatment
1.4.2 Global Male Infertility Market, by Tests
1.4.3 Global Male Infertility Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Male Infertility Market by Treatment
3.1 Global Assisted Reproductive Technology and Varicocele Surgery Market by Region
3.2 Global Medication Market by Region
Chapter 4. Global Male Infertility Market by Test
4.1 Global DNA Fragmentation Technique Market by Region
4.2 Global Oxidative Stress Analysis Market by Region
4.3 Global Computer Assisted Semen Analysis Market by Region
4.4 Global Microscopic Examination Market by Region
4.5 Global Sperm Agglutination Market by Region
4.6 Global Sperm Penetration Assay Market by Region
4.7 Global Other Test Market by Region
Chapter 5. Global Male Infertility Market by Region
5.1 North America Male Infertility Market
5.1.1 North America Male Infertility Market by Treatment
5.1.1.1 North America Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.1.1.2 North America Medication Market by Country
5.1.2 North America Male Infertility Market by Test
5.1.2.1 North America DNA Fragmentation Technique Market by Country
5.1.2.2 North America Oxidative Stress Analysis Market by Country
5.1.2.3 North America Computer Assisted Semen Analysis Market by Country
5.1.2.4 North America Microscopic Examination Market by Country
5.1.2.5 North America Sperm Agglutination Market by Country
5.1.2.6 North America Sperm Penetration Assay Market by Country
5.1.2.7 North America Other Test Market by Country
5.1.3 North America Male Infertility Market by Country
5.1.3.1 US Male Infertility Market
5.1.3.1.1 US Male Infertility Market by Treatment
5.1.3.1.2 US Male Infertility Market by Test
5.1.3.2 Canada Male Infertility Market
5.1.3.2.1 Canada Male Infertility Market by Treatment
5.1.3.2.2 Canada Male Infertility Market by Test
5.1.3.3 Mexico Male Infertility Market
5.1.3.3.1 Mexico Male Infertility Market by Treatment
5.1.3.3.2 Mexico Male Infertility Market by Test
5.1.3.4 Rest of North America Male Infertility Market
5.1.3.4.1 Rest of North America Male Infertility Market by Treatment
5.1.3.4.2 Rest of North America Male Infertility Market by Test
5.2 Europe Male Infertility Market
5.2.1 Europe Male Infertility Market by Treatment
5.2.1.1 Europe Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.2.1.2 Europe Medication Market by Country
5.2.2 Europe Male Infertility Market by Test
5.2.2.1 Europe DNA Fragmentation Technique Market by Country
5.2.2.2 Europe Oxidative Stress Analysis Market by Country
5.2.2.3 Europe Computer Assisted Semen Analysis Market by Country
5.2.2.4 Europe Microscopic Examination Market by Country
5.2.2.5 Europe Sperm Agglutination Market by Country
5.2.2.6 Europe Sperm Penetration Assay Market by Country
5.2.2.7 Europe Other Test Market by Country
5.2.3 Europe Male Infertility Market by Country
5.2.3.1 Germany Male Infertility Market
5.2.3.1.1 Germany Male Infertility Market by Treatment
5.2.3.1.2 Germany Male Infertility Market by Test
5.2.3.2 UK Male Infertility Market
5.2.3.2.1 UK Male Infertility Market by Treatment
5.2.3.2.2 UK Male Infertility Market by Test
5.2.3.3 France Male Infertility Market
5.2.3.3.1 France Male Infertility Market by Treatment
5.2.3.3.2 France Male Infertility Market by Test
5.2.3.4 Russia Male Infertility Market
5.2.3.4.1 Russia Male Infertility Market by Treatment
5.2.3.4.2 Russia Male Infertility Market by Test
5.2.3.5 Spain Male Infertility Market
5.2.3.5.1 Spain Male Infertility Market by Treatment
5.2.3.5.2 Spain Male Infertility Market by Test
5.2.3.6 Italy Male Infertility Market
5.2.3.6.1 Italy Male Infertility Market by Treatment
5.2.3.6.2 Italy Male Infertility Market by Test
5.2.3.7 Rest of Europe Male Infertility Market
5.2.3.7.1 Rest of Europe Male Infertility Market by Treatment
5.2.3.7.2 Rest of Europe Male Infertility Market by Test
5.3 Asia Pacific Male Infertility Market
5.3.1 Asia Pacific Male Infertility Market by Treatment
5.3.1.1 Asia Pacific Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.3.1.2 Asia Pacific Medication Market by Country
5.3.2 Asia Pacific Male Infertility Market by Test
5.3.2.1 Asia Pacific DNA Fragmentation Technique Market by Country
5.3.2.2 Asia Pacific Oxidative Stress Analysis Market by Country
5.3.2.3 Asia Pacific Computer Assisted Semen Analysis Market by Country
5.3.2.4 Asia Pacific Microscopic Examination Market by Country
5.3.2.5 Asia Pacific Sperm Agglutination Market by Country
5.3.2.6 Asia Pacific Sperm Penetration Assay Market by Country
5.3.2.7 Asia Pacific Other Test Market by Country
5.3.3 Asia Pacific Male Infertility Market by Country
5.3.3.1 India Male Infertility Market
5.3.3.1.1 India Male Infertility Market by Treatment
5.3.3.1.2 India Male Infertility Market by Test
5.3.3.2 China Male Infertility Market
5.3.3.2.1 China Male Infertility Market by Treatment
5.3.3.2.2 China Male Infertility Market by Test
5.3.3.3 Japan Male Infertility Market
5.3.3.3.1 Japan Male Infertility Market by Treatment
5.3.3.3.2 Japan Male Infertility Market by Test
5.3.3.4 South Korea Male Infertility Market
5.3.3.4.1 South Korea Male Infertility Market by Treatment
5.3.3.4.2 South Korea Male Infertility Market by Test
5.3.3.5 Singapore Male Infertility Market
5.3.3.5.1 Singapore Male Infertility Market by Treatment
5.3.3.5.2 Singapore Male Infertility Market by Test
5.3.3.6 Malaysia Male Infertility Market
5.3.3.6.1 Malaysia Male Infertility Market by Treatment
5.3.3.6.2 Malaysia Male Infertility Market by Test
5.3.3.7 Rest of Asia Pacific Male Infertility Market
5.3.3.7.1 Rest of Asia Pacific Male Infertility Market by Treatment
5.3.3.7.2 Rest of Asia Pacific Male Infertility Market by Test
5.4 LAMEA Male Infertility Market
5.4.1 LAMEA Male Infertility Market by Treatment
5.4.1.1 LAMEA Assisted Reproductive Technology and Varicocele Surgery Market by Country
5.4.1.2 LAMEA Medication Market by Country
5.4.2 LAMEA Male Infertility Market by Test
5.4.2.1 LAMEA DNA Fragmentation Technique Market by Country
5.4.2.2 LAMEA Oxidative Stress Analysis Market by Country
5.4.2.3 LAMEA Computer Assisted Semen Analysis Market by Country
5.4.2.4 LAMEA Microscopic Examination Market by Country
5.4.2.5 LAMEA Sperm Agglutination Market by Country
5.4.2.6 LAMEA Sperm Penetration Assay Market by Country
5.4.2.7 LAMEA Other Test Market by Country
5.4.3 LAMEA Male Infertility Market by Country
5.4.3.1 Brazil Male Infertility Market
5.4.3.1.1 Brazil Male Infertility Market by Treatment
5.4.3.1.2 Brazil Male Infertility Market by Test
5.4.3.2 Argentina Male Infertility Market
5.4.3.2.1 Argentina Male Infertility Market by Treatment
5.4.3.2.2 Argentina Male Infertility Market by Test
5.4.3.3 UAE Male Infertility Market
5.4.3.3.1 UAE Male Infertility Market by Treatment
5.4.3.3.2 UAE Male Infertility Market by Test
5.4.3.4 Saudi Arabia Male Infertility Market
5.4.3.4.1 Saudi Arabia Male Infertility Market by Treatment
5.4.3.4.2 Saudi Arabia Male Infertility Market by Test
5.4.3.5 South Africa Male Infertility Market
5.4.3.5.1 South Africa Male Infertility Market by Treatment
5.4.3.5.2 South Africa Male Infertility Market by Test
5.4.3.6 Nigeria Male Infertility Market
5.4.3.6.1 Nigeria Male Infertility Market by Treatment
5.4.3.6.2 Nigeria Male Infertility Market by Test
5.4.3.7 Rest of LAMEA Male Infertility Market
5.4.3.7.1 Rest of LAMEA Male Infertility Market by Treatment
5.4.3.7.2 Rest of LAMEA Male Infertility Market by Test
Chapter 6. Company Profiles
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[男性不妊症の世界市場2020-2026:治療別(生殖補助医療・精索静脈瘤手術、投薬)、検査別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆